These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18242396)

  • 1. Increasing the platelet count in chronic ITP.
    Nurden AT; Nurden P
    Lancet; 2008 Feb; 371(9610):362-4. PubMed ID: 18242396
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune thrombocytopenic purpura--the changing therapeutic landscape.
    Bromberg ME
    N Engl J Med; 2006 Oct; 355(16):1643-5. PubMed ID: 17050888
    [No Abstract]   [Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
    Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
    Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
    Kuter DJ; Bussel JB; Lyons RM; Pullarkat V; Gernsheimer TB; Senecal FM; Aledort LM; George JN; Kessler CM; Sanz MA; Liebman HA; Slovick FT; de Wolf JT; Bourgeois E; Guthrie TH; Newland A; Wasser JS; Hamburg SI; Grande C; Lefrère F; Lichtin AE; Tarantino MD; Terebelo HR; Viallard JF; Cuevas FJ; Go RS; Henry DH; Redner RL; Rice L; Schipperus MR; Guo DM; Nichol JL
    Lancet; 2008 Feb; 371(9610):395-403. PubMed ID: 18242413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMG 531 for chronic ITP.
    Tauro S
    N Engl J Med; 2007 Jan; 356(3):307; author reply 308. PubMed ID: 17229962
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim.
    Shigekiyo T; Sekimoto E; Shibata H; Ozaki S; Fujinaga H; Hirose T
    Platelets; 2015; 26(5):504-6. PubMed ID: 24832714
    [No Abstract]   [Full Text] [Related]  

  • 7. AMG 531 for chronic ITP.
    Prasad K
    N Engl J Med; 2007 Jan; 356(3):307-8; author reply 308. PubMed ID: 17240535
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug evaluation: AMG-531 for the treatment of thrombocytopenias.
    Rice L
    Curr Opin Investig Drugs; 2006 Sep; 7(9):834-41. PubMed ID: 17002262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review.
    Panzer S
    Vox Sang; 2008 Jan; 94(1):1-5. PubMed ID: 17973895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA approves thrombopoiesis-stimulating agent.
    Thompson CA
    Am J Health Syst Pharm; 2008 Oct; 65(19):1788. PubMed ID: 18796411
    [No Abstract]   [Full Text] [Related]  

  • 11. Romiplostim.
    Cines DB; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2008 Nov; 7(11):887-8. PubMed ID: 18974747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of thrombopoietins in the treatment of ITP.
    Kuter DJ
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):464-6. PubMed ID: 16167023
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
    George JN; Mathias SD; Go RS; Guo M; Henry DH; Lyons R; Redner RL; Rice L; Schipperus MR
    Br J Haematol; 2009 Feb; 144(3):409-15. PubMed ID: 19016720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMG 531: an investigational thrombopoiesis-stimulating peptibody.
    Nichol JL
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):723-5. PubMed ID: 16933266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in the treatment of idiopathic thrombocytopenic purpura].
    Kurata Y
    Rinsho Ketsueki; 2007 May; 48(5):355-62. PubMed ID: 17571579
    [No Abstract]   [Full Text] [Related]  

  • 16. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.
    Newland A; Caulier MT; Kappers-Klunne M; Schipperus MR; Lefrere F; Zwaginga JJ; Christal J; Chen CF; Nichol JL
    Br J Haematol; 2006 Nov; 135(4):547-53. PubMed ID: 17061981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The REMS publication paradox.
    Andrews EB; Kaye JA; Van Bennekom C
    Oncology (Williston Park); 2009 Jul; 23(8):715-7. PubMed ID: 19711587
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
    Kuter DJ
    Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of steroid therapy in idiopathic thrombocytopenic purpura].
    Fujimura K; Takamatsu Y; Kuramoto A
    Rinsho Ketsueki; 1986 Sep; 27(9):1693-9. PubMed ID: 3806979
    [No Abstract]   [Full Text] [Related]  

  • 20. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
    Bussel JB; Kuter DJ; George JN; McMillan R; Aledort LM; Conklin GT; Lichtin AE; Lyons RM; Nieva J; Wasser JS; Wiznitzer I; Kelly R; Chen CF; Nichol JL
    N Engl J Med; 2006 Oct; 355(16):1672-81. PubMed ID: 17050891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.